TRIESTE, LEOPOLDO Statistiche
TRIESTE, LEOPOLDO
DIPARTIMENTO DI FARMACIA
Longitudinal adherence trajectories to biologic disease modifying anti-rheumatic drugs in Tuscany, Italy
2021-01-01 Giometto, S; Convertino, I; Tuccori, M; Gini, R; Cazzato, M; Valdiserra, G; Cappello, E; Ferraro, S; Tillati, S; Fornili, M; Bartolini, C; Paoletti, O; Turchetti, G; Trieste, L; Lorenzoni, V; Blandizzi, C; Mosca, M; Lucenteforte, E
Trajectories of adherence to biologic disease-modifying anti-rheumatic drugs in tuscan administrative databases: The pathfinder study
2021-01-01 Convertino, I.; Giometto, S.; Gini, R.; Cazzato, M.; Fornili, M.; Valdiserra, G.; Cappello, E.; Ferraro, S.; Bartolini, C.; Paoletti, O.; Tillati, S.; Baglietto, L.; Turchetti, G.; Trieste, L.; Lorenzoni, V.; Blandizzi, C.; Mosca, M.; Tuccori, M.; Lucenteforte, E.
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases
2021-01-01 Convertino, I.; Cazzato, M.; Giometto, S.; Gini, R.; Valdiserra, G.; Cappello, E.; Ferraro, S.; Tillati, S.; Bartolini, C.; Paoletti, O.; Lorenzoni, V.; Trieste, L.; Filippi, M.; Turchetti, G.; Cristofano, M.; Blandizzi, C.; Mosca, M.; Lucenteforte, E.; Tuccori, M.
Validation test for algorithms to identify rheumatoid arthritis patients in the Tuscan healthcare administrative databases
2021-01-01 Convertino, I; Cazzato, M; Giometto, S; Gini, R; Lucenteforte, E; Valdiserra, G; Cappello, E; Ferraro, S; Tillati, S; Fornili, M; Bartolini, C; Paoletti, O; Lorenzoni, V; Trieste, L; Filippi, M; Turchetti, G; Cristofano, M; Blandizzi, C; Mosca, M; Tuccori, M
Trajectories of use of biologic disease modifying antirheumatic drugs in rheumatoid arthritis: A cohort study of Tuscan patients, Italy
2020-01-01 Convertino, I; Giometto, S; Gini, R; Cazzato, M; Valdiserra, G; Cappello, E; Ferraro, S; Fornili, M; Turchetti, G; Lorenzoni, V; Trieste, L; Mosca, M; Blandizzi, C; Tuccori, M; Lucenteforte, E
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons
2020-01-01 Convertino, Irma; Lucenteforte, Ersilia; Gini, Rosa; Lorenzoni, Valentina; Cazzato, Massimiliano; Turchetti, Giuseppe; Trieste, Leopoldo; Ferraro, Sara; Leonardi, Luca; Roberto, Giuseppe; Luciano, Nicoletta; Blandizzi, Corrado; Mosca, Marta; Tuccori, Marco
Recommendations by the Tuscan Health Authority to Use Infliximab-Biosimilar in the Clinical Practice: Safety Impact
2019-01-01 Convertino, I; Lucenteforte, E; Lorenzoni, V; Turchetti, G; Trieste, L; Roberto, G; Cazzato, M; Mosca, M; Ferraro, S; Leonardi, L; Luciano, N; Gini, R; Blandizzi, C; Tuccori, M
Switching from infliximab-originator to infliximab-biosimilar in rheumatologic patients: The clinical impact in Tuscan Region, Italy
2019-01-01 Convertino, I; Tuccori, M; Lucenteforte, E; Mosca, M; Turchetti, G; Lorenzoni, V; Trieste, L; Ferraro, S; Leonardi, L; Roberto, G; Luciano, N; Blandizzi, C; Gini, R
The Economic Impact of the Introduction of Infliximab-Biosimilar: Preliminary Results from a Study on Rheumatologic Patients in Tuscany, Italy
2019-01-01 Lorenzoni, V; Trieste, L; Mosca, M; Convertino, I; Tuccori, M; Lucenteforte, E; Ferraro, S; Leonardi, L; Roberto, G; Luciano, N; Blandizzi, C; Gini, R; Turchetti, G
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Longitudinal adherence trajectories to biologic disease modifying anti-rheumatic drugs in Tuscany, Italy | 1-gen-2021 | Giometto, S; Convertino, I; Tuccori, M; Gini, R; Cazzato, M; Valdiserra, G; Cappello, E; Ferraro, S; Tillati, S; Fornili, M; Bartolini, C; Paoletti, O; Turchetti, G; Trieste, L; Lorenzoni, V; Blandizzi, C; Mosca, M; Lucenteforte, E | |
| Trajectories of adherence to biologic disease-modifying anti-rheumatic drugs in tuscan administrative databases: The pathfinder study | 1-gen-2021 | Convertino, I.; Giometto, S.; Gini, R.; Cazzato, M.; Fornili, M.; Valdiserra, G.; Cappello, E.; Ferraro, S.; Bartolini, C.; Paoletti, O.; Tillati, S.; Baglietto, L.; Turchetti, G.; Trieste, L.; Lorenzoni, V.; Blandizzi, C.; Mosca, M.; Tuccori, M.; Lucenteforte, E. | |
| Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases | 1-gen-2021 | Convertino, I.; Cazzato, M.; Giometto, S.; Gini, R.; Valdiserra, G.; Cappello, E.; Ferraro, S.; Tillati, S.; Bartolini, C.; Paoletti, O.; Lorenzoni, V.; Trieste, L.; Filippi, M.; Turchetti, G.; Cristofano, M.; Blandizzi, C.; Mosca, M.; Lucenteforte, E.; Tuccori, M. | |
| Validation test for algorithms to identify rheumatoid arthritis patients in the Tuscan healthcare administrative databases | 1-gen-2021 | Convertino, I; Cazzato, M; Giometto, S; Gini, R; Lucenteforte, E; Valdiserra, G; Cappello, E; Ferraro, S; Tillati, S; Fornili, M; Bartolini, C; Paoletti, O; Lorenzoni, V; Trieste, L; Filippi, M; Turchetti, G; Cristofano, M; Blandizzi, C; Mosca, M; Tuccori, M | |
| Trajectories of use of biologic disease modifying antirheumatic drugs in rheumatoid arthritis: A cohort study of Tuscan patients, Italy | 1-gen-2020 | Convertino, I; Giometto, S; Gini, R; Cazzato, M; Valdiserra, G; Cappello, E; Ferraro, S; Fornili, M; Turchetti, G; Lorenzoni, V; Trieste, L; Mosca, M; Blandizzi, C; Tuccori, M; Lucenteforte, E | |
| Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons | 1-gen-2020 | Convertino, Irma; Lucenteforte, Ersilia; Gini, Rosa; Lorenzoni, Valentina; Cazzato, Massimiliano; Turchetti, Giuseppe; Trieste, Leopoldo; Ferraro, Sara; Leonardi, Luca; Roberto, Giuseppe; Luciano, Nicoletta; Blandizzi, Corrado; Mosca, Marta; Tuccori, Marco | |
| Recommendations by the Tuscan Health Authority to Use Infliximab-Biosimilar in the Clinical Practice: Safety Impact | 1-gen-2019 | Convertino, I; Lucenteforte, E; Lorenzoni, V; Turchetti, G; Trieste, L; Roberto, G; Cazzato, M; Mosca, M; Ferraro, S; Leonardi, L; Luciano, N; Gini, R; Blandizzi, C; Tuccori, M | |
| Switching from infliximab-originator to infliximab-biosimilar in rheumatologic patients: The clinical impact in Tuscan Region, Italy | 1-gen-2019 | Convertino, I; Tuccori, M; Lucenteforte, E; Mosca, M; Turchetti, G; Lorenzoni, V; Trieste, L; Ferraro, S; Leonardi, L; Roberto, G; Luciano, N; Blandizzi, C; Gini, R | |
| The Economic Impact of the Introduction of Infliximab-Biosimilar: Preliminary Results from a Study on Rheumatologic Patients in Tuscany, Italy | 1-gen-2019 | Lorenzoni, V; Trieste, L; Mosca, M; Convertino, I; Tuccori, M; Lucenteforte, E; Ferraro, S; Leonardi, L; Roberto, G; Luciano, N; Blandizzi, C; Gini, R; Turchetti, G |